Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Affordable cancer technologies: Lessons learned from the design and implementation of two randomized clinical trials to develop innovative treatments for cervical precancer

Contemporary Clinical Trials Communications(2023)10.1016/j.conctc.2023.101224Source: DataRank Database

Affordable cancer technologies: Lessons learned from the design and implementation of two randomized clinical trials to develop innovative treatments for cervical precancer is a research paper published in Contemporary Clinical Trials Communications (2023). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Download PDF

Cite:

Linked data & code

nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 0.28)OA: goldTopics (17)IDs (PubMed, PMC, OpenAlex)Annotations (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Enriquito Lu,Rachel Masch ORCID,Karla Alfaro ORCID,Jean Anderson ORCID,Miriam Cremer ORCID

Live enrichment

PubMed:38028323 PMC:PMC10663751 OpenAlex:https://openalex.org/W4388018398

Rising Tide Foundation

Grant: CCR 17-800

National Institutes of Health

Grant: UH2/UH3 CA189883

National Institutes of Health

Grant: UH2/UH3 CA189923

National Institutes of Health

Grant: 5UH3CA189883-06

CryoPen: An Innovative Treatment for Cervical Precancer in Low-Resource Setting

National Institutes of Health

Grant: 5UH3CA189923-04

Performance, safety, and efficacy of a new cyrotherapy device for cervical dyspla

FWCI

0.28

Citation Percentile

0.6%

Citation Trend

2025

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.conctc.2023.101224

publisherhttps://doi.org/10.1016/j.conctc.2023.101224

publisherhttps://api.elsevier.com/content/article/PII:S2451865423001709?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2451865423001709?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38028323

Fields of Study

Biomedical Ethics and RegulationEconomic and Financial Impacts of CancerEthics in Clinical Research03 medical and health sciences0302 clinical medicine

Keywords

Cervical cancerRandomized controlled trialClinical trialMedical physicsCancerMedicineComputer scienceSurgeryInternal medicineMedicine (General)R5-920Article